Meanwhile, it improved metabolic profiles, ameliorated hepatic steatosis, altered BA composition, and activated FXR signaling and feedback loops in diet-induced obesity mice, further confirming the promise in ameliorating NAFLD. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.